NCT07043491 Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy
| NCT ID | NCT07043491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Esophageal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2 participants |
| Start Date | 2024-11-04 |
| Primary Completion | 2025-07-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2 participants in total. It began in 2024-11-04 with a primary completion date of 2025-07-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective cohort study reviewed patients who underwent McKeown esophagectomy. All patients routinely underwent either endoscopy or esophagram for the evaluation of anastomosis on postoperative day 7. The initiation of oral intake depended on the status of anastomosis according to the assessment result of endoscopy or esophagram. All patients were followed up for six months after the assessment of anastomosis.
Eligibility Criteria
Inclusion Criteria: The inclusion criteria required patients to have routinely undergone either endoscopy or an esophagram for the postoperative evaluation of anastomosis. Exclusion Criteria: We excluded the patient with histologically confirmed benign tumors of the esophagus or esophagogastric junction and the patient who had incomplete data.
Contact & Investigator
Hong Yang, PhD.
STUDY CHAIR
Sun Yat-sen University
Frequently Asked Questions
Who can join the NCT07043491 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07043491 currently recruiting?
Yes, NCT07043491 is actively recruiting participants. Contact the research team at yanghong@wy.sysucc.org.cn for enrollment information.
Where is the NCT07043491 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT07043491 clinical trial?
NCT07043491 is sponsored by Sun Yat-sen University. The principal investigator is Hong Yang, PhD. at Sun Yat-sen University. The trial plans to enroll 2 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.